/PRNewswire/ Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on developing innovative products for neuroendocrine and metabolic disorders,.
According to news reporting out of Tartu, Estonia, by NewsRx editors, research stated,“ For many women with epilepsy, decision making about pregnancy is difficult, due mainly to the potential teratogenic risks of anti-seizure medications. Our news journalists obtained a quote from the research from the University of Tartu,“ This study was conducted to assess the.